Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease

Am J Cardiol. 2003 Apr 15;91(8):1031-2, A9. doi: 10.1016/s0002-9149(03)00135-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Child
  • Fontan Procedure*
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Mineralocorticoid Receptor Antagonists / administration & dosage*
  • Postoperative Complications
  • Protein-Losing Enteropathies / drug therapy*
  • Protein-Losing Enteropathies / etiology
  • Spironolactone / administration & dosage*

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone